Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Hypoglycaemia and counterregulation in type 2 diabetes.

Gerich JE.

Lancet. 2000 Dec 9;356(9246):1946-7. No abstract available.

PMID:
11130519
2.

Glucose counterregulation in Type 2 diabetes mellitus.

de Galan BE, Hoekstra JB.

Diabet Med. 2001 Jul;18(7):519-27. Review.

PMID:
11553179
3.

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.

Cryer PE.

Diabetologia. 2002 Jul;45(7):937-48. Epub 2002 Apr 26. Review.

PMID:
12136392
4.

[Hypoglycemia in diabetes mellitus].

Irsigler K.

Acta Med Austriaca. 1992;19(4):100-5. Review. German.

PMID:
1290316
5.

Hypoglycemia in diabetes.

Cryer PE, Davis SN, Shamoon H.

Diabetes Care. 2003 Jun;26(6):1902-12. Review.

PMID:
12766131
6.

The science of hypoglycemia in patients with diabetes.

Oyer DS.

Curr Diabetes Rev. 2013 May;9(3):195-208. Review.

PMID:
23506375
7.

Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.

Levy CJ, Kinsley BT, Bajaj M, Simonson DC.

Diabetes Care. 1998 Aug;21(8):1330-8.

PMID:
9702443
8.

Falciparum malaria-induced hypoglycaemia in a diabetic patient.

Shalev O, Tsur A, Rahav G.

Postgrad Med J. 1992 Apr;68(798):281-2.

9.

The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes.

Monnier L, Wojtusciszyn A, Colette C, Owens D.

Diabetes Technol Ther. 2011 Aug;13(8):813-8. doi: 10.1089/dia.2011.0049. Epub 2011 May 11.

PMID:
21561372
10.

Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.

Cryer PE, Gerich JE.

N Engl J Med. 1985 Jul 25;313(4):232-41. Review.

PMID:
2861565
11.

Glycaemic control in Type 2 diabetes--not for sidelining.

Narendran P.

Diabet Med. 2008 Jun;25(6):639-42. doi: 10.1111/j.1464-5491.2008.02454.x. Review. No abstract available.

PMID:
18544100
12.

Daily glycaemic variability: benefits of optimal control.

Cavalot F.

Diabetes Obes Metab. 2013 Sep;15 Suppl 2:1-2. doi: 10.1111/dom.12139. No abstract available.

PMID:
24034512
13.

Response to Jungheim and Koschinsky.

Pfützner A, Forst T.

Diabetes Care. 2002 Mar;25(3):638-9; author reply 639-40. No abstract available.

PMID:
11874972
14.

The impact of hypoglycaemia on patients admitted to hospital with medical emergencies.

Tan HK, Flanagan D.

Diabet Med. 2013 May;30(5):574-80. doi: 10.1111/dme.12123. Epub 2013 Feb 28.

PMID:
23323805
15.

Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.

Ahrén B.

Vasc Health Risk Manag. 2013;9:155-63. doi: 10.2147/VHRM.S33934. Epub 2013 Apr 24. Review.

16.

Severe hypoglycaemia from repaglinide-brotizolam drug interaction: a case report and literature review.

Khamaisi M.

Diabet Med. 2012 Sep;29(9):1214-5. doi: 10.1111/j.1464-5491.2012.03631.x. Review. No abstract available.

PMID:
22414218
17.

Evaluation of a new measure of blood glucose variability in diabetes.

Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W.

Diabetes Care. 2006 Nov;29(11):2433-8.

PMID:
17065680
18.

Composite efficacy parameters and predictors of hypoglycaemia in basal-plus insulin therapy--a combined analysis of 713 type 2 diabetic patients.

Seufert J, Brath H, Pscherer S, Borck A, Bramlage P, Siegmund T.

Diabetes Obes Metab. 2014 Mar;16(3):248-54. doi: 10.1111/dom.12211. Epub 2013 Sep 17.

PMID:
24033863
19.

What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?

Zenari L, Marangoni A.

Diabetes Obes Metab. 2013 Sep;15 Suppl 2:17-25. doi: 10.1111/dom.12143. Review.

PMID:
24034516
20.

Which patients should be evaluated for blood glucose variability?

Candido R.

Diabetes Obes Metab. 2013 Sep;15 Suppl 2:9-12. doi: 10.1111/dom.12141. Review.

PMID:
24034514

Supplemental Content

Support Center